Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/Linvoseltamab-Pivotal-Data-Presented-at-AACR-Reinforce-High-Response-Rate-that-Deepens-Over-Time-in-46382852/?utm_source=whatsapp&utm_medium=social&utm_campaign=share